secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orchestra BioMed Holdings, Inc. (OBIO)
CIK:        0001814114
Form:       8-K
Filed at:   2023-01-24T23:59:59+00:00
Accession:  0001213900-23-004618
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Sciences Acquisitions Corp 2 receives Nasdaq delisting notice for failing to hold annual meeting
--------------------------------------------------------------------------------

- Received Nasdaq notice on Jan 19, 2023 for failure to hold annual meeting within 12 months after FY2021 end (Dec 31, 2021).
- Has until March 5, 2023 to submit compliance plan; if accepted, deadline extended to June 29, 2023.
- Company does not intend to submit plan; expects to resolve via business combination with Orchestra BioMed at Jan 24, 2023 meeting.
- If business combination approved, combined company treated as newly listed; annual meeting due by Dec 31, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1814114/000121390023004618/0001213900-23-004618-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1814114/000121390023004618/ea172098-8k_healthsci2.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-004618

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer